(Q33434186)

26 July 2017

title

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia (English)

1 reference

chronic lymphocytic leukemia

26 July 2017

0 references

1 reference

1 reference

A Saven

1

1 reference

26 July 2017

C J Carrera

2

1 reference

26 July 2017

D A Carson

3

1 reference

26 July 2017

E Beutler

4

1 reference

26 July 2017

L D Piro

5

1 reference

26 July 2017

publication date

1 January 1991

1 reference

26 July 2017

1 reference

26 July 2017

volume

5 Suppl 1

1 reference

26 July 2017

page(s)

133-138

1 reference

Chronic lymphocytic leukemia: new insights into biology and therapy

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199109103394

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199109103394

Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199109103394

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199109103394

10.3109/10428199109103394

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference